Huron Consulting Group Q3 Earnings Call Highlights
Huron Consulting Group reported Q3 2026 results, with healthcare revenue up 16.5% to $255.8M, including $16.7M from acquisitions. Education revenue rose 6.6% to $138M, while commercial revenue increased 6.4% to $88.8M. The company narrowed its 2026 RBR outlook to $1.855B-$1.885B and raised adjusted non-GAAP EPS guidance to $9.20-$9.40. Huron repurchased $26.3M in shares during the quarter, with $265.9M remaining under its authorization.
How this was made
The 30-second read
Why it matters
Traders can update models for 2026 revenue, adjusted EBITDA margin, EPS, and free cash flow, and reassess risk around collections and 2027 healthcare regulatory pressure.
Market read
Company-specific guidance and cash-flow drivers are the main tradable inputs, with healthcare growth strength offset by margin and collections timing concerns.
What to watch
Commercial margin compression (13.9% vs 16.4%) and higher days sales outstanding (83 vs 79) could signal execution or billing/collections friction that investors may re-rate even if revenue growth holds.
Background
The piece summarizes Huron’s Q3 earnings call, including segment performance (healthcare, education, commercial), guidance updates, and capital allocation.
Ticker impact
Huron narrowed 2026 RBR guidance to $1.855B-$1.885B, raised non-GAAP EPS to $9.20-$9.40, and guided free cash flow to $150M-$170M.
Likely mild upside bias as EPS guidance was raised, partially offset by weaker-than-prior free cash flow expectations tied to collections.
The article provides specific, company-issued guidance ranges (RBR, adjusted EBITDA margin, EPS, and FCF) plus the stated drivers (collection timing and project mix), which are direct inputs to valuation and near-term positioning.
Market effects
Reinforces demand durability in healthcare and managed services consulting, while highlighting regulatory-driven uncertainty for 2027 Medicaid-related reimbursement.
No specific regional market catalyst beyond US healthcare policy exposure.
Limited direct global impact; primarily US healthcare and education/public-sector consulting demand.
Counterpoint
The raised EPS range may not translate into near-term cash generation because management explicitly cites collection timing and working-capital dynamics as the reason for reduced free cash flow.
Key entities
- companyHuron Consulting Group
NASDAQ-listed professional services firm reporting Q3 segment results and updating 2026 guidance and cash-flow expectations.
